NCT05900180

Brief Summary

Examination of frequency of therapy and effect on clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

April 20, 2023

Last Update Submit

April 28, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Articulation and intelligibility

    Scores on the following standardized measures: Goldman Fristoe Test of Articulation- Third Edition (GFTA-3) ; Average Standard Score range is from 86-114; an increase in standard score indicates improvement in intelligibility.

    Baseline, immediately after treatment (up to 4 months)

  • Change in Receptive vocabulary skills

    Scores on the following standardized measure: Receptive One Word Picture Vocabulary Test- Fourth Edition (ROVPVT-4); Average Standard Score range is from 85-115; an increase in standard score indicates improvement in understanding vocabulary.

    Baseline, immediately after treatment (up to 4 months)

  • Change in Expressive vocabulary skills

    Scores on the following standardized measure: Expressive One Word Picture Vocabulary Test- Fourth Edition (EOWPVT-4); Average Standard Score range is from 85-115; an increase in standard score indicates improvement in understanding or labeling vocabulary.

    Baseline, immediately after treatment (up to 4 months)

  • Change in Receptive and expressive early language skills

    Scores on the following standardized measures: Receptive-Expressive Emergent Language Scale- Fourth Edition (REEL-4); Average Standard Score range is from 90-109; an increase in standard score indicates improvement in language ability score.

    Baseline, immediately after treatment (up to 4 months)

Secondary Outcomes (1)

  • Home Exercise Plan (HEP) provision

    up to 4 months

Study Arms (2)

Every-other-week therapy with home programming

ACTIVE COMPARATOR

Receipt of standard speech therapy care (every-other-week) for 8.0 sessions

Behavioral: Speech Therapy

Weekly therapy with home programming

EXPERIMENTAL

Receipt of speech therapy care (every week) for 8.0 sessions

Behavioral: Speech Therapy

Interventions

Speech TherapyBEHAVIORAL

Delivery of speech therapy services

Every-other-week therapy with home programmingWeekly therapy with home programming

Eligibility Criteria

Age18 Months - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Medical order for speech therapy
  • Patients eligible for speech therapy at Connecticut Children's (qualify for receptive, expressive language and/or articulation therapy)
  • Diagnosis of communication disorder.ICD-10 codes will be utilized pertaining to expressive, receptive language and articulation disorders (ICD-10 code specific to patient: F80.0, F80.1, F80.2, F80.4, F80.9, R47.89, R41.841)
  • Patient recommended for individual (i.e. not group) treatment
  • months to 16 years of age
  • Completed 1 plan of care (POC) with a duration of 8 sessions
  • Attended at least 80% of scheduled visits during their plan of care period (still completing 8 sessions of therapy, may have extended time to completion).
  • Services for a full 8-session plan of care.

You may not qualify if:

  • \- Seeking speech therapy care for treatment of disorders related to diagnosis of voice, feeding, fluency, and/or cognition
  • Patient unable to complete standardized tests (EOWPVT-4, ROWPVT-4, GFTA-3, REEL-4)
  • Patients in group speech therapy
  • Patients younger than 18 months or older than 16 years of age
  • Not willing to complete a full POC (8 sessions)
  • Unable/unwilling to attend 80% of scheduled visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Connecticut Children's Medical Center

Hartford, Connecticut, 06106, United States

Location

Related Publications (1)

  • Van Epps VM, Daur-Schierholz M, Dortenzio M, Mendillo E, Urzua J, Brimacombe M, Hinderer KA. How changes to frequency of treatment and mode of treatment improved paediatric speech-language pathology services: A pragmatic clinical trial. Int J Speech Lang Pathol. 2026 Mar 8:1-12. doi: 10.1080/17549507.2026.2630835. Online ahead of print.

MeSH Terms

Conditions

Communication Disorders

Interventions

Speech Therapy

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Rehabilitation of Speech and Language DisordersRehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Virginia Van Epps, M.Ed.

    Connecticut Children's Medical Center

    PRINCIPAL INVESTIGATOR
  • Mary Dortenzio, MS

    Connecticut Children's Medical Center

    STUDY DIRECTOR
  • Jodi Urzua, MS

    Connecticut Children's Medical Center

    STUDY DIRECTOR
  • Emma Mendillo, MA

    Connecticut Children's Medical Center

    STUDY DIRECTOR
  • Morgan Daur-Schierholz, MS

    Connecticut Children's Medical Center

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2023

First Posted

June 12, 2023

Study Start

January 1, 2023

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations